Xiaoli Xu
China Pharmaceutical University(CN)Fudan University Shanghai Cancer Center(CN)
Publications by Year
Research Areas
Heat shock proteins research, Computational Drug Discovery Methods, interferon and immune responses, Protein Degradation and Inhibitors, Genomics, phytochemicals, and oxidative stress
Most-Cited Works
- → Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis(2014)245 cited
- → Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions(2019)197 cited
- → Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective(2019)132 cited
- → NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction(2016)122 cited
- → Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO(2004)115 cited
- → Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer(2019)100 cited